Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Morel

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Transfusion Medicine (Oxford, England)|March 1, 1994
Human platelet alloantigen typing: PCR analysis is not a substitute for serological methodsM C Morel-Kopp, S Clemenceau, M H Aurousseau, et al.
The Biochemical Journal|July 6, 2001
Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alphaIIb or beta3 allows the expression of a fully functional integrin alphaIIb(beta3): effect of beta3GFP on alphaIIb(beta3) ligand bindingS Plançon, M C Morel-Kopp, E Schaffner-Reckinger, et al.
Human Immunology|April 1, 1996
Genetic susceptibility and anti-human platelet antigen 5b alloimmunization role of HLA class II and TAP genesG Semana, T Zazoun, M Alizadeh, et al.
Transfusion Medicine (Oxford, England)|December 1, 1992
Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapyC Kaplan, M C Morel-Kopp, S Clemenceau, et al.
Infection and Immunity|February 1, 1992
Human platelet aggregation by Yersinia pseudotuberculosis is mediated by invasinM Simonet, P Triadou, C Frehel, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2006
Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assayJ L Curnow, M-C Morel-Kopp, C Roddie, et al.
Internal Medicine Journal|May 31, 2007
Use of a functional assay to diagnose protein S deficiency; inappropriate testing yields equivocal resultsA M Johnston, M Aboud, M-C Morel-Kopp, et al.
Pathologie-Biologie|October 1, 1994
[Fetal-neonatal thrombocytopenia of immunologic origin: current aspects]C Kaplan, M C Morel-Kopp, F Forestier, et al.
Transfusion Medicine (Oxford, England)|June 1, 1995
Platelet phenotyping in carriers for Glanzmann's thrombasthenia: a simple screening test for assessment of the molecular defectM C Morel-Kopp, S Clemenceau, N Schlegel, et al.
Transfusion Medicine (Oxford, England)|December 1, 1992
Anti-HPA-4b (anti-Yuk(a)) neonatal alloimmune thrombocytopenia: first report in a Caucasian familyM C Morel-Kopp, B Blanchard, V Kiefel, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Transfusion Medicine (Oxford, England)|March 1, 1994
Human platelet alloantigen typing: PCR analysis is not a substitute for serological methodsM C Morel-Kopp, S Clemenceau, M H Aurousseau, et al.
The Biochemical Journal|July 6, 2001
Green fluorescent protein (GFP) tagged to the cytoplasmic tail of alphaIIb or beta3 allows the expression of a fully functional integrin alphaIIb(beta3): effect of beta3GFP on alphaIIb(beta3) ligand bindingS Plançon, M C Morel-Kopp, E Schaffner-Reckinger, et al.
Human Immunology|April 1, 1996
Genetic susceptibility and anti-human platelet antigen 5b alloimmunization role of HLA class II and TAP genesG Semana, T Zazoun, M Alizadeh, et al.
Transfusion Medicine (Oxford, England)|December 1, 1992
Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapyC Kaplan, M C Morel-Kopp, S Clemenceau, et al.
Infection and Immunity|February 1, 1992
Human platelet aggregation by Yersinia pseudotuberculosis is mediated by invasinM Simonet, P Triadou, C Frehel, et al.
Journal of Thrombosis and Haemostasis : JTH|December 15, 2006
Reduced fibrinolysis and increased fibrin generation can be detected in hypercoagulable patients using the overall hemostatic potential assayJ L Curnow, M-C Morel-Kopp, C Roddie, et al.
Internal Medicine Journal|May 31, 2007
Use of a functional assay to diagnose protein S deficiency; inappropriate testing yields equivocal resultsA M Johnston, M Aboud, M-C Morel-Kopp, et al.
Pathologie-Biologie|October 1, 1994
[Fetal-neonatal thrombocytopenia of immunologic origin: current aspects]C Kaplan, M C Morel-Kopp, F Forestier, et al.
Transfusion Medicine (Oxford, England)|June 1, 1995
Platelet phenotyping in carriers for Glanzmann's thrombasthenia: a simple screening test for assessment of the molecular defectM C Morel-Kopp, S Clemenceau, N Schlegel, et al.
Transfusion Medicine (Oxford, England)|December 1, 1992
Anti-HPA-4b (anti-Yuk(a)) neonatal alloimmune thrombocytopenia: first report in a Caucasian familyM C Morel-Kopp, B Blanchard, V Kiefel, et al.
Pageof 5